EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

OM‐85, a Bacterial Lysate, Reduces Pulmonary Nodule Malignant Probability: A Retrospective Study

Mengting Sun, Yuqing Ni, Xueling Wu iD, Hao Tian, Yijun Song, Yinzhou Feng iD, Yunxin Guo, Yong Zhang, Jun Yin, Charles A Powell, Chunxue Bai, Yuanlin Song und 1 weitere

The Clinical Respiratory Journal · 2025-07 · 19 (7)

DOI: 10.1111/crj.70109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, online erschienen am 21.07.2025. Verfasst von Mengting Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Solitary Pulmonary Nodule, Multiple Pulmonary Nodules, Cell Extracts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Fujian Provincial Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The current clinical management of pulmonary nodules relies heavily on CT follow‐up, without early intervention. This retrospective study investigated the efficacy of OM‐85, a standardized lysate of human respiratory bacteria, in the treatment of high‐risk pulmonary nodules detected by computed tomography (CT) in patients with chronic bronchitis.

Methods

This study included 72 patients (93 enrolled nodules) who underwent treatment with OM‐85 and a matched control group of 90 patients (111 control nodules). The primary endpoint included reduced size of high‐risk ground glass nodules based on thin‐layer CT scans during follow‐up. Flow cytometry, multiplex immunofluorescence (mIF) analysis, and scRNA‐seq data were employed to determine differences in the immune cell subsets between the treatment and control groups.

Results

Oral OM‐85 treatment significantly reduced lung nodule diameter ( p = 0.031), the risk probability of malignancy ( p = 0.003), and the likelihood of clinical disease progression ( p = 0.0091). The effects of OM‐85 treatment were more pronounced in older patients (> 65‐year‐old) ( p = 0.029) and those with longer follow‐up cycles (> 200 days) ( p = 0.011). The peripheral blood samples showed a significantly higher proportion of natural killer (NK) cells in the treatment group. Furthermore, mIF staining of the pulmonary nodules and scRNA‐seq data demonstrated a higher percentage of NK cells in the treatment group compared with the control group ( p = 0.0003).

Conclusion

OM‐85 reduced the size of high‐risk pulmonary nodules and decreased the risk of malignant probability and disease progression in patients with chronic bronchitis by increasing the proportion of NK cells. Therefore, OM‐85 is a potential drug for the treatment of high‐risk pulmonary nodules in patients with chronic bronchitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsSolitary Pulmonary NoduleMultiple Pulmonary NodulesCell ExtractsBronchitis, ChronicHumansMaleRetrospective StudiesFemaleAgedMiddle AgedTomography, X-Ray ComputedTreatment OutcomeDisease ProgressionFollow-Up StudiesAdultBacterial Lysates

Stichwörter der Autor:innen

OM‐85immunomodulatorlung nodulesmalignant progression

Substanzen

Broncho-VaxomCell ExtractsBacterial Lysates

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital Fudan University, Shanghai, China.
  • Department of Pulmonology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • School of Information Science and Technology, Fudan University, Shanghai, China.
  • Department of Thoracic Surgery, Zhongshan Hospital Fudan University, Shanghai, China.
  • Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Shanghai Institute of Respiratory Diseases, Shanghai, China.

ORCID-Profile: Xueling Wu, Yinzhou Feng, Dawei Yang

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Fujian Provincial Department of Science and Technology
  • Science and Technology Commission of Shanghai Municipality
  • National Key Research and Development Program of China
  • R&D Program of Guangzhou National Laboratory
  • Shanghai Municipal Science and Technology Major Project
  • Shanghai Three-Year Action Plan to Strengthen the Construction of Public Health System

Zitieren

APA

Sun, M., Ni, Y., Wu, X., Tian, H., Song, Y., Feng, Y., Guo, Y., Zhang, Y., Yin, J., Powell, C. A., Bai, C., Song, Y., & Yang, D. (2025). OM‐85, a Bacterial Lysate, Reduces Pulmonary Nodule Malignant Probability: A Retrospective Study. The Clinical Respiratory Journal, 19(7). https://doi.org/10.1111/crj.70109

Vancouver

Sun M, Ni Y, Wu X, Tian H, Song Y, Feng Y, et al. OM‐85, a Bacterial Lysate, Reduces Pulmonary Nodule Malignant Probability: A Retrospective Study. The Clinical Respiratory Journal. 2025;19(7). doi:10.1111/crj.70109

BibTeX
@article{Sun2025,
  author = {Sun, Mengting and Ni, Yuqing and Wu, Xueling and Tian, Hao and Song, Yijun and Feng, Yinzhou and Guo, Yunxin and Zhang, Yong and Yin, Jun and Powell, Charles A and Bai, Chunxue and Song, Yuanlin and Yang, Dawei},
  title = {OM‐85, a Bacterial Lysate, Reduces Pulmonary Nodule Malignant Probability: A Retrospective Study},
  journal = {The Clinical Respiratory Journal},
  year = {2025},
  volume = {19},
  number = {7},
  doi = {10.1111/crj.70109}
}
Kostenlos starten →